Javascript must be enabled to continue!
Dyslipidemia in insulin dependent diabetic children
View through CrossRef
Background: Children and adolescents with insulin-dependent diabetes mellitus (IDDM) are at high risk of metabolic disorders that may interfere with lipid metabolism and predispose to dyslipidemia. Objective: To detect the incidence of dyslipidemia and associated factors in children with IDDM in Diyala. Patients and Methods: This was a case-control study that included a total of 100 children with type 1 diabetes mellitus(T1DM) and 100 age- and gender-matched non-diabetic children who presented to the Pediatric Department/Al-Batool Teaching Hospital during the period from April 2022 to April 2023. Demographic data included the child's age, gender, weight, mother’s educational level, mother's job, child's educational level, school attendance, and physical activity. Clinical data included systolic and diastolic blood pressure, HbA1c, family history of illness, disease duration, type of insulin, and insulin dose. Fasting lipid profile and hemoglobin A1c investigations were done for the study groups, and the data were statistically analyzed. Results: The overall dyslipidemia in IDDM children and controls was 46% and 8%, respectively, with a highly significant difference. The mean age and weight in diabetic patients with dyslipidemia were 8.23±3.63 years and 28.96±13.31 kg, respectively, which was higher than that of normolipidemic diabetic patients (10.72±3.23 years and 34.22±12.14 kg, respectively) with significant differences. Furthermore, 28.26% of mothers of dyslipidemia-.diabetic patients were employed, compared with only 11.11% of normolipidemic-diabetic patients, a significant difference. A family history of DM was reported in 47.83% and 27.78% of dyslipidemic and normolipidemic diabetic patients, respectively, with a significant difference. Conclusion: The incidence of dyslipidemia among diabetic children in Diyala is 46%. Older age, increased body weight, and a mother’s job as an employer are significantly associated with the development of dyslipidemia in insulin-dependent diabetes mellitus patients. Keywords: Dyslipidemia, Diabetes mellitus, Children, Diyala.
Diyala Journal of Medicine
Title: Dyslipidemia in insulin dependent diabetic children
Description:
Background: Children and adolescents with insulin-dependent diabetes mellitus (IDDM) are at high risk of metabolic disorders that may interfere with lipid metabolism and predispose to dyslipidemia.
Objective: To detect the incidence of dyslipidemia and associated factors in children with IDDM in Diyala.
Patients and Methods: This was a case-control study that included a total of 100 children with type 1 diabetes mellitus(T1DM) and 100 age- and gender-matched non-diabetic children who presented to the Pediatric Department/Al-Batool Teaching Hospital during the period from April 2022 to April 2023.
Demographic data included the child's age, gender, weight, mother’s educational level, mother's job, child's educational level, school attendance, and physical activity.
Clinical data included systolic and diastolic blood pressure, HbA1c, family history of illness, disease duration, type of insulin, and insulin dose.
Fasting lipid profile and hemoglobin A1c investigations were done for the study groups, and the data were statistically analyzed.
Results: The overall dyslipidemia in IDDM children and controls was 46% and 8%, respectively, with a highly significant difference.
The mean age and weight in diabetic patients with dyslipidemia were 8.
23±3.
63 years and 28.
96±13.
31 kg, respectively, which was higher than that of normolipidemic diabetic patients (10.
72±3.
23 years and 34.
22±12.
14 kg, respectively) with significant differences.
Furthermore, 28.
26% of mothers of dyslipidemia-.
diabetic patients were employed, compared with only 11.
11% of normolipidemic-diabetic patients, a significant difference.
A family history of DM was reported in 47.
83% and 27.
78% of dyslipidemic and normolipidemic diabetic patients, respectively, with a significant difference.
Conclusion: The incidence of dyslipidemia among diabetic children in Diyala is 46%.
Older age, increased body weight, and a mother’s job as an employer are significantly associated with the development of dyslipidemia in insulin-dependent diabetes mellitus patients.
Keywords: Dyslipidemia, Diabetes mellitus, Children, Diyala.
Related Results
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Defects in insulin-receptor function have been associated with insulin-resistant states such as obesity and non-insulin-dependent diabetes mellitus (NIDDM). Several types of mutati...
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
Introduction:
Non-diabetic individuals with type II diabetic parents are more susceptible to develop Diabetes. Visfatin; an adipocytokine and an enzyme is linked with glucose...
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
Abstract
Abstract 4908
Insulin resistance can be a major problem in patients with diabetes mellitus. Although multiple reasons can result in this prob...
940-P: Porous Insulin Microneedles for Diabetes Treatment
940-P: Porous Insulin Microneedles for Diabetes Treatment
Introduction and Objective: Patients with type 1 and type 2 diabetes are subjected to insulin injection therapies. Repeated subcutaneous insulin administrations leads to physiologi...
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
The aim of this study is to evaluate the cost-effectiveness of continuous subcutaneous insulin infusion (CSII) to multiple daily insulin injection (MDI) either with analogues or w...
Pathogenesis of Type 2 Diabetes
Pathogenesis of Type 2 Diabetes
AbstractThe sections in this article are:Insulin Secretion in T2DMFasting Insulin ConcentrationGlucose‐Stimulated Insulin SecretionOther Abnormalities in Insulin Secretion in T2DMM...

